Takeshi Takamoto
Overview
Explore the profile of Takeshi Takamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takamoto T, Mihara Y, Nishioka Y, Ichida A, Kawaguchi Y, Akamatsu N, et al.
Int J Clin Oncol
. 2025 Feb;
30(3):417-426.
PMID: 39907863
Hepatocellular carcinoma (HCC) remains a significant global health challenge, with over 800,000 new cases diagnosed annually. This comprehensive review examines current surgical approaches and emerging multidisciplinary strategies in HCC treatment....
2.
Kiritani S, Kawaguchi Y, Nishioka Y, Mihara Y, Ichida A, Takamoto T, et al.
Eur J Surg Oncol
. 2025 Feb;
51(5):109633.
PMID: 39892087
Introduction: Hepatopancreatoduodenectomy (HPD) is necessary to achieve a reliable margin-negative resection for widespread perihilar cholangiocarcinoma (PhCC), yet data on long-term outcomes following HPD for PhCC remain limited. Materials And Methods:...
3.
Murase Y, Esaki M, Mizui T, Takamoto T, Nara S, Ban D, et al.
Surgery
. 2024 Dec;
180:109029.
PMID: 39740608
Background: Lymph node dissection is required for many pancreatic neuroendocrine neoplasms. However, the need for such dissection has rarely been examined in detail by the tumor size, tumor location, or...
4.
Takamoto T, Nara S, Ban D, Mizui T, Miyata A, Esaki M
Surgery
. 2024 Dec;
180:109026.
PMID: 39740600
Background: With the advent of improved chemotherapy options, neoadjuvant chemotherapy has gained acceptance as a multidisciplinary treatment approach for localized pancreatic ductal adenocarcinoma. This study aimed to clarify whether neoadjuvant...
5.
Takamoto T, Nara S, Ban D, Mizui T, Mukai M, Esaki M, et al.
Eur J Surg Oncol
. 2024 Dec;
51(2):109461.
PMID: 39631231
Background: While liver resection remains the best curative option for hepatocellular carcinoma (HCC), it is unclear whether the consistent progress of multidisciplinary approaches in managing HCC over several decades has...
6.
Takayama M, Ito K, Karako K, Mihara Y, Sasaki S, Ichida A, et al.
J Hepatobiliary Pancreat Sci
. 2024 Nov;
32(1):58-68.
PMID: 39547943
Background/purpose: Contrast-enhanced intraoperative ultrasonography (CE-IOUS) is crucial for detecting colorectal liver metastases (CLM) during surgery. Although artificial intelligence shows potential in diagnostic systems, its application in CE-IOUS is limited. Methods:...
7.
Uemura S, Ban D, Esaki M, Nara S, Takamoto T, Mizui T, et al.
World J Surg
. 2024 Sep;
48(10):2496-2504.
PMID: 39278820
Background: Postoperative pancreatic fistula (POPF) is a major complication of distal pancreatectomy (DP). Although the visceral fat area (VFA) is a risk factor for POPF in DP, its measurement is...
8.
Ito S, Takamoto T, Nara S, Ban D, Mizui T, Nagata H, et al.
World J Surg Oncol
. 2024 Sep;
22(1):247.
PMID: 39267117
Background: The prognostic implications of the RAS status in colorectal cancer liver metastasis (CRLM) remain unclear. This study investigated the prognostic significance of RAS status after curative hepatectomy, focusing on...
9.
Sugawara S, Sone M, Umino R, Ban D, Itou C, Kimura S, et al.
Abdom Radiol (NY)
. 2024 Aug;
49(12):4365-4372.
PMID: 39120716
Purpose: This study aimed to evaluate the feasibility, safety, diagnostic yield, and technical aspects of percutaneous abdominal lavage cytology screening (PACS) in patients with resectable pancreatic cancer. Methods: This single-center,...
10.
Kawasaki Y, Hijioka S, Nagashio Y, Ohba A, Maruki Y, Takeshita K, et al.
Endosc Ultrasound
. 2024 Jul;
13(2):115-122.
PMID: 38947747
Background And Objectives: EUS tissue acquisition (EUS-TA) is the standard diagnostic method for solid pancreatic lesions (SPLs); however, there are few reports on EUS-TA results for SPLs ≤10 mm. Furthermore,...